In the current study, we aimed to examine the potential association between elevated levels of COMP in tumors from patients with CRC and levels of fibrosis, tumor-infiltrating populations of immune cells, and expression of PD-L1 on immune cells and tumor cells. The gene discussed is COMP; the disease is colorectal carcinoma.